|
Accueil > Actualité
Eli Lilly: FDA approves new migraine treatment
(CercleFinance.com) - Eli Lilly has won US FDA approval for an injected drug designed to treat episodic cluster headaches in adults.
After being trained by a healthcare professional, patients can administer the Emgality antibody at home through subcutaneous injections at the onset of a cluster headache period, and then monthly until the end of the period. The medecine was first approved by the FDA in September 2018 for the preventive treatment of migraine in adults. Copyright (c) 2019 CercleFinance.com. All rights reserved. |
19/04/2024 12:16
AST Groupeouverture d'une procédure de sauvegarde 19/04/2024 12:05 Theranexusle titre grimpe après un essai prometteur 19/04/2024 11:55 Airbusnouveaux hélicoptères pour l'armée britannique 19/04/2024 11:10 Renaultle titre chute après l'avertissement de Nissan 19/04/2024 11:07 Arganune nomination au directoire 19/04/2024 10:50 Econocomconfirme une hausse du CA comprise entre 3 et 5% Tous les articles sociétés |
